title: Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells.
abstract: The bioactive phospholipid lysophosphatidic acid (LPA) promotes cell proliferation, survival, and migration by acting on cognate G protein-coupled receptors named LPA(1), LPA(2), and LPA(3). We profiled gene expression of LPA receptors in androgen-dependent and androgen-insensitive prostate cancer cells and found that LPA(1) gene is differentially expressed in androgen-insensitive and LPA-responsive but not androgen-dependent and LPA-resistant cells. In human prostate specimens, expression of LPA(1) gene was significantly higher in the cancer compared with the benign tissues. The androgen-dependent LNCaP cells do not express LPA(1) and do not proliferate in response to LPA stimulation, implying LPA(1) transduces cell growth signals. Accordingly, stable expression of LPA(1) in LNCaP cells rendered them responsive to LPA-induced cell proliferation and decreased their doubling time in serum. Implantation of LNCaP-LPA(1) cells resulted in increased rate of tumor growth in animals compared with those tumors that developed from the wild-type cells. Growth of LNCaP cells depends on androgen receptor activation, and we show that LPA(1) transduces Galphai-dependent signals to promote nuclear localization of androgen receptor and cell proliferation. In addition, treatment with bicalutamide inhibited LPA-induced cell cycle progression and proliferation of LNCaP-LPA(1) cells. These results suggest the possible utility of LPA(1) as a drug target to interfere with progression of prostate cancer.
authors.affiliation: Department of Surgery, Duke University of Medical Center, North Carolina 27710, USA.
authors.forename: Rishu
authors.initials: R
authors.lastname: Guo
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Kasbohm
authors.forename: Puneeta
authors.initials: P
authors.lastname: Arora
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Sample
authors.forename: Babak
authors.initials: B
authors.lastname: Baban
authors.forename: Neetu
authors.initials: N
authors.lastname: Sud
authors.forename: Perumal
authors.initials: P
authors.lastname: Sivashanmugam
authors.forename: Nader H
authors.initials: NH
authors.lastname: Moniri
authors.forename: Yehia
authors.initials: Y
authors.lastname: Daaka
mesh_terms: D015152:Blotting, Northern; D002453:Cell Cycle / Q000502:physiology; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D049109:Cell Proliferation; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D008856:Microscopy, Fluorescence; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D011944:Receptors, Androgen / Q000235:genetics; D049368:Receptors, Lysophosphatidic Acid / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
chemical_list: D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D011944:Receptors, Androgen; D049368:Receptors, Lysophosphatidic Acid